In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Alnylam's current price aligns closely with its PERT-weighted fair value, indicating fair valuation with minimal implied upside (2.5%). Analyst targets suggest potential for significant price variability, contrasting with conservative DCF and P/E estimates. Strong liquidity and profitability scores reduce downside risk, reflecting a balanced risk/reward profile.